2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Vitamin D Deficiency
20
Prostatic Neoplasms
17
Polycystic Ovary Syndrome
10
Neoplasms
9
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Osteoporosis
5
Myelodysplastic Syndromes
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
Bupivacaine
2
Ultrasonography
1
Therapeutics
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Ralfinamide
1
Radiofrequency Ablation
1
Nerve Conduction Studies
1
Musculoskeletal Manipulations
1
Methylprednisolone
1
Lidoderm
1
Lidocaine
1
Indocyanine Green
1
Electromyography
1
Dry Needling
1
Decompression
1
Cryosurgery
1
Cholecalciferol
1
Botulinum Toxins, Type A
1
Bevacizumab
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroma
×
Cholecalciferol
×
Clear all
NCT04115982
2021-08-31
D3NERV
University Hospital, Caen
Phase 3
Unknown
72 enrolled